Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuli Li

Showing results (171-180 of 233) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerAthanassios Argiris, Shuli Li, Panayiotis Savvides, et al.
The Oncologist|December 30, 2017
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and AnalysisLova Sun, Shuli Li, Areej El-Jawahri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2018
Phase I Trial of Brentuximab Vedotin for Steroid-Refractory Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationZachariah DeFilipp, Shuli Li, Maria E Kempner, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Blood Advances|January 4, 2018
Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host diseaseZachariah DeFilipp, Rosalynn M Nazarian, Areej El-Jawahri, et al.
BMC Medicine|December 30, 2025
Dimethyl itaconate suppresses dendritic cell and CD8<sup>+</sup> T cell responses to halt vitiligoYinghan Wang, Yuhan Chen, Jingjing Ma, et al.
Bone Marrow Transplantation|May 28, 2020
Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantationA Katie Maurer, Shuli Li, Bradley D Hunter, et al.
The Journal of Investigative Dermatology|February 9, 2017
Simvastatin Protects Human Melanocytes from H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress by Activating Nrf2Yuqian Chang, Shuli Li, Weinan Guo, et al.
Plos One|April 4, 2014
Epidermal or dermal specific knockout of PHD-2 enhances wound healing and minimizes ischemic injuryAndrew S Zimmermann, Shane D Morrison, Michael S Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemiaJennifer R Brown, Haesook T Kim, Shuli Li, et al.
Pageof 24

Showing results (171-180 of 233) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerAthanassios Argiris, Shuli Li, Panayiotis Savvides, et al.
The Oncologist|December 30, 2017
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and AnalysisLova Sun, Shuli Li, Areej El-Jawahri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2018
Phase I Trial of Brentuximab Vedotin for Steroid-Refractory Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationZachariah DeFilipp, Shuli Li, Maria E Kempner, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Blood Advances|January 4, 2018
Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host diseaseZachariah DeFilipp, Rosalynn M Nazarian, Areej El-Jawahri, et al.
BMC Medicine|December 30, 2025
Dimethyl itaconate suppresses dendritic cell and CD8<sup>+</sup> T cell responses to halt vitiligoYinghan Wang, Yuhan Chen, Jingjing Ma, et al.
Bone Marrow Transplantation|May 28, 2020
Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantationA Katie Maurer, Shuli Li, Bradley D Hunter, et al.
The Journal of Investigative Dermatology|February 9, 2017
Simvastatin Protects Human Melanocytes from H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress by Activating Nrf2Yuqian Chang, Shuli Li, Weinan Guo, et al.
Plos One|April 4, 2014
Epidermal or dermal specific knockout of PHD-2 enhances wound healing and minimizes ischemic injuryAndrew S Zimmermann, Shane D Morrison, Michael S Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemiaJennifer R Brown, Haesook T Kim, Shuli Li, et al.
Pageof 24